Guobang Pharma Ltd (605507) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.038x

Based on the latest financial reports, Guobang Pharma Ltd (605507) has a cash flow conversion efficiency ratio of 0.038x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥311.27 Million ≈ $45.55 Million USD) by net assets (CN¥8.28 Billion ≈ $1.21 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 605507 days of operational coverage to measure how many days the company can operate on defensive assets alone.

Guobang Pharma Ltd - Cash Flow Conversion Efficiency Trend (2017–2025)

This chart illustrates how Guobang Pharma Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Guobang Pharma Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Guobang Pharma Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Aotecar New Energy Technology Co Ltd SHE:002239	0.082x
Goldsun Building Materials Co Ltd TW:2504	0.053x
Guild Holdings Co NYSE:GHLD	0.064x
Hunan Friendship&Apollo Commercial Co Ltd SHE:002277	0.016x
Karooooo Ltd JSE:KRO	0.151x
Zhejiang Xinhua Chemical Co Ltd SHG:603867	0.034x
Flow Traders BV AS:FLOW	-1.463x
Yuhuan CNC Machine Tool Co Ltd SHE:002903	0.006x

Annual Cash Flow Conversion Efficiency for Guobang Pharma Ltd (2017–2025)

The table below shows the annual cash flow conversion efficiency of Guobang Pharma Ltd from 2017 to 2025. For the full company profile with market capitalisation and key ratios, see Guobang Pharma Ltd market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥8.56 Billion ≈ $1.25 Billion	CN¥559.28 Million ≈ $81.84 Million	0.065x	-25.49%
2024-12-31	CN¥8.05 Billion ≈ $1.18 Billion	CN¥706.41 Million ≈ $103.37 Million	0.088x	+26.26%
2023-12-31	CN¥7.44 Billion ≈ $1.09 Billion	CN¥516.76 Million ≈ $75.62 Million	0.069x	-51.12%
2022-12-31	CN¥7.15 Billion ≈ $1.05 Billion	CN¥1.02 Billion ≈ $148.82 Million	0.142x	+611.99%
2021-12-31	CN¥6.35 Billion ≈ $928.57 Million	CN¥-176.18 Million ≈ $-25.78 Million	-0.028x	-111.84%
2020-12-31	CN¥3.27 Billion ≈ $479.11 Million	CN¥767.70 Million ≈ $112.34 Million	0.234x	+39.13%
2019-12-31	CN¥2.62 Billion ≈ $382.78 Million	CN¥440.86 Million ≈ $64.51 Million	0.169x	-19.35%
2018-12-31	CN¥2.59 Billion ≈ $379.31 Million	CN¥541.68 Million ≈ $79.27 Million	0.209x	+211.60%
2017-12-31	CN¥2.21 Billion ≈ $323.00 Million	CN¥148.03 Million ≈ $21.66 Million	0.067x	--

About Guobang Pharma Ltd

SHG:605507 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.24 Billion

CN¥8.51 Billion CNY

Market Cap Rank

#8128 Global

#1957 in China

Share Price

CN¥15.22

Change (1 day)

-0.59%

52-Week Range

CN¥14.96 - CN¥29.25

All Time High

CN¥43.71